News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Biotech giant Genmab to acquire Seattle company ProfoundBio in $1.8B deal
Seattle-based biotech company ProfoundBio, specializing in drugs for ovarian and endometrial cancers, will be acquired by Danish firm Genmab in a $1.8 billion all-cash deal,

From timber to tech: Spokane’s startup scene is ready for its big breakthrough
Spokane, Washington is emerging as a dynamic tech hub, buoyed by its prestigious universities and thriving startup ecosystem. With respected institutions like Gonzaga University and

Seattle Children’s receives $50 million gift for pediatric cancer research
Seattle Children’s received a $50 million donation from the William Lawrence and Blanche Hughes Foundation, marking a significant contribution towards pediatric cancer research, especially childhood

Fred Hutch unveils results of new blood test that detects colon cancer
Fred Hutch Cancer Center, located in Seattle, announced a new blood test that can be used to detect colorectal cancer. According to a study published

Otsuka and Lundbeck’s schizophrenia treatment gains EC approval
Lundbeck, which has offices in Bothell, Washington, announced the European Commission approved Otsuka Pharmaceutical Europe and H Lundbeck’s Abilify Maintena 720mg/960mg (aripiprazole) for schizophrenia treatment.

AGC Biologics to manufacture first FDA approved gene therapy for metachromatic leukodystrophy
The U.S. Food and Drug Administration has cleared AGC Biologics’ Milan site to begin manufacturing of Orchard Therapeutics’ Lenmeldy (atidarsagene autotemcel), a gene therapy for

Workforce challenge: Cell & gene therapy manufacturing
Seattle’s nascent approach to building up the cell and gene therapy workforce could provide lessons for other regions to develop the field and fill their

Out of the Lab and Into the Factory
The Seattle-area life science sector has built out a niche for itself in biomanufacturing to support cell therapy, a type of biologics where human cells

Seattle health care tech company PreemptiveAI launches from stealth
Seattle-based health tech startup PreemptiveAI raised $6.4 million in funding and announced a partnership with Duke University to test its predictive healthcare technology. The platform

Seattle biotech nonprofit lands funding to improve vaccine responses
The Access to Advanced Health Institute (AAHI) in Seattle has secured the first phase of up to $12.7 million in funding from the Medical CBRN

Perspective Therapeutics raises $87 million on heels of big January round
Seattle-based Perspective Therapeutics Inc. recently raised $87.4 million through a private placement, following a $89.8 million fundraising effort in January. This financing includes acquiring a

The Secret Behind Washington’s Biotech Boom
A recent issue of the Washington Department of Commerce’s ‘Choose Washington’ magazine, highlights Washington’s fast-growing life science industry. According to the article, life science companies
